These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 33853691)

  • 1. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity.
    Zuo T; Liu Q; Zhang F; Yeoh YK; Wan Y; Zhan H; Lui GCY; Chen Z; Li AYL; Cheung CP; Chen N; Lv W; Ng RWY; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Microbiome; 2021 Apr; 9(1):91. PubMed ID: 33853691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
    Zhang F; Wan Y; Zuo T; Yeoh YK; Liu Q; Zhang L; Zhan H; Lu W; Xu W; Lui GCY; Li AYL; Cheung CP; Wong CK; Chan PKS; Chan FKL; Ng SC
    Gastroenterology; 2022 Feb; 162(2):548-561.e4. PubMed ID: 34687739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the Composition of Intestinal DNA Virome in Patients With COVID-19.
    Lu ZH; Zhou HW; Wu WK; Fu T; Yan M; He Z; Sun SW; Ji ZH; Shao ZJ
    Front Cell Infect Microbiol; 2021; 11():790422. PubMed ID: 34900762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
    Zuo T; Zhan H; Zhang F; Liu Q; Tso EYK; Lui GCY; Chen N; Li A; Lu W; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Oct; 159(4):1302-1310.e5. PubMed ID: 32598884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pediatric gut bacteriome and virome in response to SARS-CoV-2 infection.
    Piazzesi A; Pane S; Del Chierico F; Romani L; Campana A; Palma P; Putignani L
    Front Cell Infect Microbiol; 2024; 14():1335450. PubMed ID: 38318164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiome Alterations in COVID-19.
    Zuo T; Wu X; Wen W; Lan P
    Genomics Proteomics Bioinformatics; 2021 Oct; 19(5):679-688. PubMed ID: 34560321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea.
    Park SK; Lee CW; Park DI; Woo HY; Cheong HS; Shin HC; Ahn K; Kwon MJ; Joo EJ
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1387-1394.e2. PubMed ID: 32534042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.
    Galperine T; Choi Y; Pagani JL; Kritikos A; Papadimitriou-Olivgeris M; Méan M; Scherz V; Opota O; Greub G; Guery B; Bertelli C;
    BMC Infect Dis; 2023 Aug; 23(1):537. PubMed ID: 37596518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.
    Zuo T; Liu Q; Zhang F; Lui GC; Tso EY; Yeoh YK; Chen Z; Boon SS; Chan FK; Chan PK; Ng SC
    Gut; 2021 Feb; 70(2):276-284. PubMed ID: 32690600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
    Yeoh YK; Zuo T; Lui GC; Zhang F; Liu Q; Li AY; Chung AC; Cheung CP; Tso EY; Fung KS; Chan V; Ling L; Joynt G; Hui DS; Chow KM; Ng SSS; Li TC; Ng RW; Yip TC; Wong GL; Chan FK; Wong CK; Chan PK; Ng SC
    Gut; 2021 Apr; 70(4):698-706. PubMed ID: 33431578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut virome and microbiome dynamics before and after SARS-CoV-2 infection in women living with HIV and their infants.
    Maqsood R; Holland LA; Wu LI; Begnel ER; Adhiambo J; Owiti P; Chohan BH; Gantt S; Kinuthia J; Wamalwa D; Ojee E; Richardson BA; Slyker J; Lehman DA; Lim ES
    Gut Microbes; 2024; 16(1):2394248. PubMed ID: 39185682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA Viromics of Southern California Wastewater and Detection of SARS-CoV-2 Single-Nucleotide Variants.
    Rothman JA; Loveless TB; Kapcia J; Adams ED; Steele JA; Zimmer-Faust AG; Langlois K; Wanless D; Griffith M; Mao L; Chokry J; Griffith JF; Whiteson KL
    Appl Environ Microbiol; 2021 Nov; 87(23):e0144821. PubMed ID: 34550753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
    Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
    Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
    Sencio V; Machelart A; Robil C; Benech N; Hoffmann E; Galbert C; Deryuter L; Heumel S; Hantute-Ghesquier A; Flourens A; Brodin P; Infanti F; Richard V; Dubuisson J; Grangette C; Sulpice T; Wolowczuk I; Pinet F; Prévot V; Belouzard S; Briand F; Duterque-Coquillaud M; Sokol H; Trottein F
    Gut Microbes; 2022; 14(1):2018900. PubMed ID: 34965194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.
    Reinold J; Farahpour F; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Hoffmann D; Buer J; Witzke O; Westendorf AM; Kehrmann J
    Front Cell Infect Microbiol; 2021; 11():747816. PubMed ID: 34869058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications.
    Bai GH; Lin SC; Hsu YH; Chen SY
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
    Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
    BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated gut virome and bacteriome dynamics in COVID-19 patients.
    Cao J; Wang C; Zhang Y; Lei G; Xu K; Zhao N; Lu J; Meng F; Yu L; Yan J; Bai C; Zhang S; Zhang N; Gong Y; Bi Y; Shi Y; Chen Z; Dai L; Wang J; Yang P
    Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33678150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.